Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
26.5 /100
Rank 112 out of 131 Industries -
Advance/Decline
11/11
-
No. of Companies22
-
Avg. Market Cap3,466
-
Price to Earning Ratio34.59
-
Price to Earning Growth Ratio0.50
-
Price to Book Ratio8.32
-
Return on Equity13.67
-
Return on Capital Employed-
-
Return on Assets7.58
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %-111.10 %
-
Net Profit Growth Qtr YoY %-131.11 %
-
Net Profit Growth Qtr QoQ %-356.92 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc |
|
321.9
|
17.6
|
L
 -1.2%
H
17.4
17.9
|
L
 -9.5%
H
16.7
19.5
|
L
 -17.8%
H
16.7
22.5
|
L
 -15.6%
H
16.7
22.9
|
L
 -46.8%
H
16.7
38.3
|
L
 -70.7%
H
16.7
69.6
|
L
 -81.5%
H
16.7
107.9
|
L
 -69.4%
H
16.7
138.0
|
| Argen X SE (ADR) |
|
45,056.7
|
728.1
|
L
 -2.0%
H
727.4
744.9
|
L
 -2.8%
H
705.9
757.7
|
L
 -12.6%
H
705.9
852.8
|
L
 -18.2%
H
705.9
897.0
|
L
 27.5%
H
510.1
934.6
|
L
 113.3%
H
327.7
934.6
|
L
 135.7%
H
248.2
934.6
|
L
H
17.3
934.6
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
0.8
|
L
H
0.7
0.8
|
L
 -6.3%
H
0.7
1.1
|
L
 -6.3%
H
0.7
1.1
|
L
 -39.0%
H
0.6
1.3
|
L
 -74.2%
H
0.6
6.2
|
L
 -65.1%
H
0.6
6.2
|
L
 -98.1%
H
0.6
99
|
L
 -98.0%
H
0.6
620
|
| Niagen Bioscience Inc |
|
391.6
|
4.9
|
L
 -6.3%
H
4.8
5.2
|
L
 0.4%
H
4.8
5.8
|
L
 -4.5%
H
4.7
5.8
|
L
 -25.7%
H
4.7
7.1
|
L
 -37.9%
H
4.7
14.7
|
L
 230.4%
H
1.3
14.7
|
L
 -54.5%
H
1.2
14.7
|
L
 8.7%
H
1.2
23.7
|
| Cronos Grp Inc |
|
970.4
|
2.6
|
L
 1.6%
H
2.5
2.6
|
L
 -1.5%
H
2.5
2.7
|
L
 -3.8%
H
2.5
2.8
|
L
 -8.2%
H
2.4
3.4
|
L
 32.6%
H
1.6
3.4
|
L
 32.6%
H
1.6
3.4
|
L
 -73.7%
H
1.6
10.9
|
L
H
0.2
25.1
|
| Enveric Biosciences Inc |
|
2.7
|
2.0
|
L
 -0.5%
H
1.9
2.0
|
L
 -6.2%
H
1.8
2.2
|
L
 -8.4%
H
1.8
2.5
|
L
 -80.9%
H
1.8
10.3
|
L
 -90.5%
H
1.8
22.2
|
L
 -99.4%
H
1.8
1256.4
|
L
 -100.0%
H
1.8
44100
|
L
 -100.0%
H
1.8
12150000
|
| ZeroStack Corp |
|
16.9
|
7.0
|
L
 -0.6%
H
6.9
7.1
|
L
 6.8%
H
6.4
7.3
|
L
 -32.3%
H
6.3
10.3
|
L
 -26.8%
H
5.9
15.0
|
L
 -71.9%
H
5.9
47
|
L
 -97.5%
H
5.9
280.5
|
L
H
5.9
16731
|
L
H
5.9
16731
|
| IM Cannabis Corp |
|
5.0
|
0.8
|
L
 3.7%
H
0.8
0.9
|
L
 20%
H
0.7
0.9
|
L
 -27.6%
H
0.7
1.2
|
L
 -50%
H
0.7
2.1
|
L
 -53.9%
H
0.7
7.1
|
L
 -80.8%
H
0.4
8.6
|
L
 -99.8%
H
0.4
525.0
|
L
H
0.4
697.8
|
| Lifevantage Corp |
|
67.5
|
5.3
|
L
 1.5%
H
5.0
5.4
|
L
 10%
H
4.6
5.4
|
L
 7.1%
H
4.3
5.4
|
L
 -20.6%
H
3.9
6.8
|
L
 -66.4%
H
3.9
17.6
|
L
 50.9%
H
3.0
27.4
|
L
 -45%
H
3.0
27.4
|
L
 -44.1%
H
2.9
27.4
|
| Mannatech Inc |
|
12.1
|
6.4
|
L
 -3.6%
H
6.2
6.8
|
L
 -5.7%
H
6.2
6.8
|
L
 -14.4%
H
6.2
7.6
|
L
 -30.3%
H
6.2
9.5
|
L
 -46.0%
H
6.2
12.5
|
L
 -65.5%
H
6.2
19.6
|
L
 -64.6%
H
6.2
49.1
|
L
 -66.3%
H
6.2
49.1
|
| Natural Alternatives Intl Inc |
|
16.8
|
2.7
|
L
 -1.1%
H
2.7
2.9
|
L
 3.8%
H
2.7
2.9
|
L
 -18.1%
H
2.3
3.5
|
L
 -17.6%
H
2.3
5.0
|
L
 -28.6%
H
2.3
5.0
|
L
 -69.6%
H
2.3
9.7
|
L
 -83.1%
H
2.3
19.9
|
L
 -75.4%
H
2.3
19.9
|
| Nature`s Sunshine Products Inc |
|
433.2
|
24.8
|
L
 -1.3%
H
24.6
27.9
|
L
 -8.2%
H
23.6
27.9
|
L
 -2.4%
H
23.6
28.1
|
L
 13.4%
H
20.9
28.1
|
L
 68.0%
H
11.0
28.1
|
L
 193.7%
H
8.3
28.1
|
L
 37.9%
H
7.9
28.1
|
L
 175.4%
H
5.5
28.1
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
8.1
|
2.3
|
L
 65.2%
H
1.4
2.4
|
L
 81.0%
H
1.2
2.4
|
L
 68.9%
H
1.2
2.4
|
L
 -40%
H
1.1
4.7
|
L
 -98.4%
H
1.1
141
|
L
 -99.5%
H
1.1
542.9
|
L
 -99.9%
H
1.1
4360
|
L
H
1.1
12200
|
| PharmaCyte Biotech Inc |
|
6.9
|
0.7
|
L
H
0.7
0.7
|
L
 -4.2%
H
0.6
0.8
|
L
 -12.8%
H
0.6
0.8
|
L
 -34.6%
H
0.6
1.1
|
L
 -61.8%
H
0.6
1.8
|
L
 -76.7%
H
0.6
3.2
|
L
 -97.7%
H
0.6
33.5
|
L
 -99.3%
H
0.6
253.4
|
| AIxCrypto Holdings Inc |
|
5.7
|
1.1
|
L
 -7.6%
H
1.1
1.2
|
L
 4.8%
H
1.0
1.3
|
L
 -19.7%
H
0.9
1.4
|
L
 -56.7%
H
0.9
3.0
|
L
 -63.5%
H
0.9
8.8
|
L
 -98.0%
H
0.1
68.5
|
L
 -99.9%
H
0.1
1700
|
L
 -100.0%
H
0.1
468750
|
| Revolution Medicines Inc |
|
19,736.1
|
99.6
|
L
 0.7%
H
96.5
100.1
|
L
 -0.9%
H
96.5
102
|
L
 3.8%
H
93.8
107.5
|
L
 27.9%
H
73
124.5
|
L
 170.5%
H
29.2
124.5
|
L
 379.7%
H
15.5
124.5
|
L
 112.1%
H
14.1
124.5
|
L
H
14.1
124.5
|
| Upexi Inc |
|
71.4
|
1.0
|
L
 9.6%
H
0.9
1.0
|
L
 32.1%
H
0.9
1.2
|
L
 5.1%
H
0.5
1.2
|
L
 -58.0%
H
0.5
2.6
|
L
 -60.5%
H
0.5
22.5
|
L
 -98.7%
H
0.5
91.5
|
L
H
0.5
187.4
|
L
H
0.5
187.4
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
2.6
|
0.8
|
L
H
0.7
0.8
|
L
 -6.3%
H
0.7
1.1
|
L
 -6.3%
H
0.7
1.1
|
L
 -39.0%
H
0.6
1.3
|
L
 -77.1%
H
0.6
6.2
|
L
 -96.5%
H
0.6
46.9
|
L
 -99.8%
H
0.6
460
|
L
 -99.8%
H
0.6
6200
|
| FitLife Brands Inc |
|
138.3
|
14.7
|
L
 0.9%
H
14.5
14.8
|
L
 -2.5%
H
14.2
15.3
|
L
 2.6%
H
13.4
15.3
|
L
 -14.1%
H
13.4
18.5
|
L
 6.0%
H
9.8
21.0
|
L
 -11.0%
H
9.8
35.5
|
L
 -11.0%
H
9.8
35.5
|
L
 -11.0%
H
9.8
35.5
|
| Abivax (ADR) |
|
8,880.6
|
112.3
|
L
 -2.6%
H
110.8
114.4
|
L
 1.1%
H
107.8
117.5
|
L
 -5.8%
H
105.8
133.4
|
L
 -11.9%
H
105.8
148.8
|
L
 1646.7%
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| Synergy CHC Corp |
|
14.5
|
1.3
|
L
 -0.8%
H
1.3
1.4
|
L
 -3.0%
H
1.3
1.5
|
L
 -26.7%
H
1.3
1.8
|
L
 -28.3%
H
1.3
2.2
|
L
 -64.2%
H
1.3
4.1
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
| iBio Inc |
|
83.9
|
2.4
|
L
 2.1%
H
2.3
2.5
|
L
 -9.7%
H
2.3
2.9
|
L
 7.1%
H
2.0
3.1
|
L
 -13.5%
H
1.7
3.1
|
L
 203.8%
H
0.6
3.8
|
L
 203.8%
H
0.6
3.8
|
L
 203.8%
H
0.6
3.8
|
L
 203.8%
H
0.6
3.8
|